PATENT CLAIM ANALYSIS

Application Number: 16178137
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "142100"]

Abstract:
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Claim (Index 17):
The composition of  claim 16 , wherein the composition has osmolality of about 180 to 420 mOsM; the composition is suitable for administration to a subject as a single dose; and the dose contains about 40 mg of adalimumab.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 98.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16023205', '15799851', '15726165', '15726195', '15729243']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7960941397066604
- 35 USC 102 Novelty (BERT): 0.6305052889667858
- Combined Prediction Score: 0.779535254632673
- Mean Citation Score: 596.822944
- Max Citation Score: 609.71796
- Similarity Product: 545.9574080308485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test